SITAREDDYS-M
80,55 R$
Preço máximo ao consumidor (CMED)
Analogs of SITAREDDYS-M
Find cheaper analogs and generic equivalents for SITAREDDYS-M.
Princípio ativo: sitagliptine hydrochloride, metformine hydrochloride
Visão geral do produto
About SITAREDDYS-M
SITAREDDYS-M is a medication containing the active ingredient Sitagliptin, classified as Dipeptidyl Peptidase 4 Inhibitor. Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. It is in the dipeptidyl peptidase-4 (DPP-4) inhibitor class and works by increasing the production of insulin and decreasing the production of glucagon by the pancreas.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a.
- Use only as directed on the product label or by a healthcare professional.
- Follow the authorised product information for dosing and duration of use.
Active Ingredient & Action
Sitagliptin, the active ingredient in SITAREDDYS-M, belongs to the Dipeptidyl Peptidase 4 Inhibitor class. 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking SITAREDDYS-M. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use SITAREDDYS-M for extended periods without medical advice.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.